344 related articles for article (PubMed ID: 14647973)
1. Beta-adrenoceptor polymorphisms.
Leineweber K; Büscher R; Bruck H; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
Leineweber K
Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
[TBL] [Abstract][Full Text] [Related]
3. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
4. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
Leineweber K; Heusch G
Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of human beta-adrenergic receptor genes and their association with obesity.
Liu ZQ; Mo W; Huang Q; Zhou HH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):359-67. PubMed ID: 17611309
[TBL] [Abstract][Full Text] [Related]
6. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
[TBL] [Abstract][Full Text] [Related]
7. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
8. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?
Vriz O; Minisini R; Zito C; Boccato E; Fimiani F; Pirisi M; Facciolo C; Limongelli G; Bossone E; Calabrò P
Int J Cardiol; 2015 Nov; 199():189-92. PubMed ID: 26197406
[TBL] [Abstract][Full Text] [Related]
9. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
[TBL] [Abstract][Full Text] [Related]
10. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
Leineweber K; Brodde OE
Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
[TBL] [Abstract][Full Text] [Related]
11. Beta2-adrenoceptor gene polymorphisms.
Brodde OE; Leineweber K
Pharmacogenet Genomics; 2005 May; 15(5):267-75. PubMed ID: 15864127
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.
Nonen S; Yamamoto I; Liu J; Maeda M; Motomura T; Igarashi T; Fujio Y; Azuma J
Biol Pharm Bull; 2008 Feb; 31(2):295-8. PubMed ID: 18239290
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults.
Kelsey RM; Alpert BS; Dahmer MK; Krushkal J; Quasney MW
Psychophysiology; 2010 Sep; 47(5):863-73. PubMed ID: 20374546
[TBL] [Abstract][Full Text] [Related]
14. [Myocardial hypertrophy in patients with hypertensive disease: the role of genetic polymorphism of beta-adrenoreactive structures].
Minushkina LO; Nikitin AG; Brazhnik VA; Brovkin AN; Nosikov VV; Zateĭshchikov DA
Kardiologiia; 2010; 50(1):9-15. PubMed ID: 20144152
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
16. The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.
Leineweber K; Frey UH; Tenderich G; Toliat MR; Zittermann A; Nürnberg P; Körfer R; Siffert W; Heusch G
Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):357-65. PubMed ID: 20803192
[TBL] [Abstract][Full Text] [Related]
17. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
18. Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan.
Chou YC; Tsai CN; Lee YS; Pei JS
Pediatr Int; 2012 Feb; 54(1):111-6. PubMed ID: 22115535
[TBL] [Abstract][Full Text] [Related]
19. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
20. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
